Status:
UNKNOWN
Subconjunctival Bupivacaine in Strabismus Surgery
Lead Sponsor:
Fayoum University
Conditions:
Anesthesia, Local
Eligibility:
All Genders
14-30 years
Phase:
NA
Brief Summary
This study aimed to assess the effectiveness of the Subconjunctival bupivacaine on postoperative pain in Strabismus surgery under general anaesthesia.
Detailed Description
40 patients will schedule for elective Strabismus surgery under general anaesthesia and randomly allocated into two groups to receive Subconjunctival 0.5%Bupivacaine group(B) or Subconjunctival placeb...
Eligibility Criteria
Inclusion
- All patients aged 14 \_30 years old with body mass index 18\_28kg/m.
- American Anaesthesiologist Association physical states I,II.
- singed informed consent to participate in the study and were scheduled for strabismus operations under general anaesthesia.
Exclusion
- were patients with chronic pain.
- ocular hypertension.
- inability to communicate.
- history of hematological disease.
- allergy to local anesthetic drugs.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04782960
Start Date
April 1 2021
End Date
May 1 2021
Last Update
March 4 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.